Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase NA 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 13 Stomach Neoplasms 3 Neoplasm Metastasis 3 Carcinoma, Hepatocellular 3 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Tertiary Lymphoid Structures 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Osteosarcoma 1 Mesothelioma, Malignant 1 Melanoma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Esophageal Squamous Cell Carcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Brain Neoplasms 1

Interventions

Ifosfamide 5 Temozolomide 4 surufatinib 2 irinotecan sucrosofate 2 Vincristine 2 Radiotherapy 2 Nivolumab 2 Irinotecan 2 Gemcitabine 2 Etoposide 2 Doxorubicin 2 vactosertib 1 temsirolimus 1 talazoparib 1 silmitasertib 1 selinexor 1 regorafenib 1 pepinemab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 pazopanib 1 olaparib 1 lutetium Lu 177 dotatate 1 liposomal doxorubicin 1 lenvatinib 1 etoposide phosphate 1 endostar protein 1 dostarlimab 1 dinutuximab 1 copanlisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Osteosarcoma × regorafenib × Clear all

NCT05395741 2026-03-25

Regbone

Institute of Mother and Child, Warsaw, Poland

Phase 1/2 Active not recruiting

Bone Neoplasms, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡